Metformin
also Glucophage
Diabetes drug that lowers blood sugar
Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polyendocrine metabolic ovarian syndrome, and is sometimes used as an off-label adjunct to lessen the risk of metabolic syndrome in people who take antipsychotic medication. It has been shown to inhibit inflammation, and is not associated with weight gain. Metformin is taken by mouth.
Read “Metformin” on Wikipedia and its adverse effects · text from Wikipedia, CC BY-SA 4.0
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research 10
- Robust Metformin Nanosystem Promotes Hair Growth in Androgenetic Alopecia
- Topical Metformin Compared with Clobetasol Propionate for Alopecia Areata: Clinical Outcomes from a Comparative Study.
- Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin
- A Systematic Review on Clinical Evidence for Topical Metformin: Old Medication With New Application
- Efficacy of metformin in human single hair fibre by ATR-FTIR spectroscopy coupled with statistical analysis
- New onset of alopecia in a young woman with end-stage renal disease
- Metformin Promotes the Hair-Inductive Activity of Three-Dimensional Aggregates of Epidermal and Dermal Cells Self-Assembled in vitro
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Stimulation of Hair Growth by Small Molecules that Activate Autophagy
- Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Insulin resistance is not a predictor of response to low-dose oral metformin therapy in patients with CCCA: A retrospective review
- Case Report: Identification of two novel ALMS1 variants in a patient with a ciliopathy resembling Alström syndrome
- Emerging pharmacotherapies for androgenetic alopecia
- Bio-inspired suction cup microneedle loaded fusion membrane targeting nano-drug delivery system treat androgenetic alopecia
- Topical Metformin Compared with Clobetasol Propionate for Alopecia Areata: Clinical Outcomes from a Comparative Study.
- Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report
- Cyproterone acetate for hirsutism
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect
Posts 13
- Clascoterone Phase 3 Results and Efficacy
- So what about the risk of type 2 diabetes with 5ARIs?
- New ingredients - GHK-Cu or Acetyl Tetrapeptide-3?
- Dear Dut users,have you noticed any metabolic changes with use of the drug?
- Dr. Bloxham's Verteporfin Trial
- Finasteride- how serious is the increase in estrogen?
- What is everyone's assessment of pyrilutamide 1.0% topical as a adjunct treatment?
- Does anyone have experience with Retrograde alopecia? Can’t seem to find any info on it.
- Finasteride users, do you take anything to inhibit aromatization ?
- Here's a list of Doctors prescribing Oral Minoxidil along with pricing, location (online/offline) etc.
- Post Oral Minoxidil Results Here (before/after) .
- How to increase neurosteroids when using Finasteride?
- Hair Regrowth with Novel Hemp Extract - anyone seen this??